Journal
STEM CELLS
Volume 30, Issue 12, Pages 2709-2719Publisher
WILEY-BLACKWELL
DOI: 10.1002/stem.1250
Keywords
Embryonic stem cells; Induced pluripotent Stem cells; Signal transduction; Bone
Categories
Funding
- National Institutes of Health [NIH-U01 HL099776, RC1 HL100490, RC2 DE020771]
- California Institute Regenerative Medicine [RL1-00662-1]
Ask authors/readers for more resources
Marfan syndrome (MFS) is a hereditary disease caused by mutations in the gene encoding Fibrillin-1 (FBN1) and characterized by a number of skeletal abnormalities, aortic root dilatation, and sometimes ectopia lentis. Although the molecular pathogenesis of MFS was attributed initially to a structural weakness of the fibrillin-rich microfibrils within the extracellular matrix, more recent results have documented that many of the pathogenic abnormalities in MFS are the result of alterations in TGF beta signaling. Mutations in FBN1 are therefore associated with increased activity and bioavailability of TGF-beta 1, which is suspected to be the basis for phenotypical similarities of FBN1 mutations in MFS and mutations in the receptors for TGF beta in Marfan syndrome-related diseases. We have previously demonstrated that unique skeletal phenotypes observed in human embryonic stem cells carrying the monogenic FBN1 mutation (MFS cells) are faithfully phenocopied by cells differentiated from induced pluripotent-stem cells (MFSiPS) derived independently from MFS patient fibroblasts. In this study, we aimed to determine further the biochemical features of transducing signaling(s) in MFS stem cells and MFSiPS cells highlighting a crosstalk between TGF beta and BMP signaling. Our results revealed that enhanced activation of TGF beta signaling observed in MFS cells decreased their endogenous BMP signaling. Moreover, exogenous BMP antagonized the enhanced TGF beta signaling in both MFS stem cells and MFSiPS cells therefore, rescuing their ability to undergo osteogenic differentiation. This study advances our understanding of molecular mechanisms underlying the pathogenesis of bone loss/abnormal skeletogenesis in human diseases caused by mutations in FBN1. STEM CELLS 2012; 30: 2709-2719
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available